NMPA Approval

Mixed Protamine Human Insulin Injection (30R)

Approval Number

国药准字SJ20160045

Registration Date

August 23, 2021

Previous Approval Numbers

S20160045

Drug Information

Generic Name

30/70混合重组人胰岛素注射液

Trade Name

优泌林 70/30

Dosage Form

注射剂

Strength

3ml:300单位(笔芯)

Drug Type

生物制品

Registration Date

August 23, 2021

Expiry Date

August 22, 2026

Company Address

24 boulevard Vital Bouhot CS 50004 92521 NEUILLY SUR SEINE CEDEX France

Company Address

Zone Industrielle 2 rue du colonel Lilly 67640 Fegersheim,France

Empowering clinical research with data-driven insights and AI-powered tools.

30/70混合重组人胰岛素注射液 - NMPA 批准文号 | MedPath